Literature DB >> 26596918

Diagnostic Modalities for Inflammatory Bowel Disease: Serologic Markers and Endoscopy.

Clarence Clark1, Jacquelyn Turner2.   

Abstract

The evaluation, diagnosis, and monitoring of inflammatory bowel disease (IBD) has improved significantly over the past few decades. However, differentiation and management of the subtypes of IBD (Crohn's disease, ulcerative colitis, and indeterminate colitis) can still be challenging. The evolution of serologic markers has improved our understanding of the pathogenesis and natural history of IBD. In addition, advancements in endoscopy and endoscopic scoring systems have improved the accuracy of diagnosis and the efficacy of surveillance of IBD patients. This article reviews the recent literature on serologic markers, endoscopy, and endoscopy scoring systems.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endoscopy; Inflammatory bowel disease; Serologic markers

Mesh:

Substances:

Year:  2015        PMID: 26596918     DOI: 10.1016/j.suc.2015.07.008

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  2 in total

1.  ANCA-Associated Vasculitis in Inflammatory Bowel Disease.

Authors:  Jocelyn X Jiang; Karuna Keat; Sanjay Swaminathan
Journal:  Dig Dis Sci       Date:  2019-05-15       Impact factor: 3.199

2.  Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.

Authors:  Amanda D Williams; Olga Y Korolkova; Amos M Sakwe; Timothy M Geiger; Samuel D James; Roberta L Muldoon; Alan J Herline; J Shawn Goodwin; Michael G Izban; Mary K Washington; Duane T Smoot; Billy R Ballard; Maria Gazouli; Amosy E M'Koma
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.